139 related articles for article (PubMed ID: 25917075)
1. LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cells.
Zienert E; Eke I; Aust D; Cordes N
Cancer Lett; 2015 Aug; 364(1):17-24. PubMed ID: 25917075
[TBL] [Abstract][Full Text] [Related]
2. The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b.
Brun J; Fromigué O; Dieudonné FX; Marty C; Chen J; Dahan J; Wei Y; Marie PJ
Bone; 2013 Mar; 53(1):6-12. PubMed ID: 23201222
[TBL] [Abstract][Full Text] [Related]
3. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells.
Hehlgans S; Eke I; Storch K; Haase M; Baretton GB; Cordes N
Radiother Oncol; 2009 Sep; 92(3):362-70. PubMed ID: 19665245
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
Jin X; Jiao X; Jiao J; Zhang T; Cui B
Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
[TBL] [Abstract][Full Text] [Related]
7. Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins.
Park J; Will C; Martin B; Gullotti L; Friedrichs N; Buettner R; Schneider H; Ludwig S; Wixler V
FASEB J; 2008 Jul; 22(7):2508-20. PubMed ID: 18356303
[TBL] [Abstract][Full Text] [Related]
8. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
Wang Q; Wang X; Tian X; Tang R; Xu X
J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
[TBL] [Abstract][Full Text] [Related]
9. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.
Hehlgans S; Eke I; Cordes N
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e669-76. PubMed ID: 22483702
[TBL] [Abstract][Full Text] [Related]
10. A novel colon cancer gene therapy using rAAV‑mediated expression of human shRNA-FHL2.
Wu Y; Guo Z; Zhang D; Zhang W; Yan Q; Shi X; Zhang M; Zhao Y; Zhang Y; Jiang B; Cheng T; Bai Y; Wang J
Int J Oncol; 2013 Nov; 43(5):1618-26. PubMed ID: 24008552
[TBL] [Abstract][Full Text] [Related]
11. Matrix mechanics controls FHL2 movement to the nucleus to activate p21 expression.
Nakazawa N; Sathe AR; Shivashankar GV; Sheetz MP
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6813-E6822. PubMed ID: 27742790
[TBL] [Abstract][Full Text] [Related]
12. The role of FHL2 in wound healing and inflammation.
Wixler V
FASEB J; 2019 Jul; 33(7):7799-7809. PubMed ID: 30939249
[TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer.
Gabriel B; Mildenberger S; Weisser CW; Metzger E; Gitsch G; Schüle R; Müller JM
Anticancer Res; 2004; 24(2B):921-7. PubMed ID: 15161045
[TBL] [Abstract][Full Text] [Related]
14. Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP/TAZ protein signaling.
Gopal U; Mowery Y; Young K; Pizzo SV
J Biol Chem; 2019 Sep; 294(38):13939-13952. PubMed ID: 31358620
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo.
Qian Z; Mao L; Fernald AA; Yu H; Luo R; Jiang Y; Anastasi J; Valk PJ; Delwel R; Le Beau MM
Leukemia; 2009 Sep; 23(9):1650-7. PubMed ID: 19369964
[TBL] [Abstract][Full Text] [Related]
16. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.
Chen YH; Wu ZQ; Zhao YL; Si YL; Guo MZ; Han WD
Chin Med J (Engl); 2012 Jul; 125(13):2329-33. PubMed ID: 22882857
[TBL] [Abstract][Full Text] [Related]
17. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells.
Xu D; Allsop SA; Witherspoon SM; Snider JL; Yeh JJ; Fiordalisi JJ; White CD; Williams D; Cox AD; Baines AT
Carcinogenesis; 2011 Apr; 32(4):488-95. PubMed ID: 21262926
[TBL] [Abstract][Full Text] [Related]
18. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
[TBL] [Abstract][Full Text] [Related]
19. FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1.
Sun J; Yan G; Ren A; You B; Liao JK
Circ Res; 2006 Sep; 99(5):468-76. PubMed ID: 16888242
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
